OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
111
Results
Show all
Save search
Copy query
Show results for
Unknown
(95)
Genomics
(13)
Proteomics
(2)
Transcriptomics
(1)
Organisms
Homo sapiens
(14)
Repository
EGA
(13)
MassIVE
(2)
biostudies-arrayexpress
(1)
Technology Type
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0
(1)
Instrument Platform
Q Exactive Plus
(1)
Publication Date
2015
(1)
2023
(1)
2013
(1)
Study type
Comparative genomic hybridization by array
(1)
Release Date
2022
(12)
2025
(10)
2024
(10)
2021
(10)
2019
(9)
2020
(8)
2015
(6)
2018
(5)
2023
(4)
2017
(4)
2013
(4)
2012
(4)
2016
(3)
2014
(3)
2011
(3)
2026
(1)
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324.
Not available
S-EPMC3107747
|
biostudies-literature
Cite
Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers.
Not available
S-EPMC10941025
|
biostudies-literature
Cite
Human muscle-specific A-kinase anchoring protein polymorphisms modulate the susceptibility to cardiovascular diseases by altering cAMP/PKA signaling.
Not available
S-EPMC6087776
|
biostudies-literature
Cite
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Not available
S-EPMC3675689
|
biostudies-literature
Cite
Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor.
Not available
S-EPMC3595426
|
biostudies-literature
Cite
Genomic analysis reveals that immune function genes are strongly linked to clinical outcome in the North Central Cancer Treatment Group n9831 Adjuvant Trastuzumab Trial.
Not available
S-EPMC4334774
|
biostudies-literature
Cite
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
Not available
S-EPMC3515768
|
biostudies-literature
Cite
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC4878106
|
biostudies-literature
Cite
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.
Not available
S-EPMC4050205
|
biostudies-literature
Cite
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Not available
S-EPMC5773840
|
biostudies-literature
Cite
Previous
page
1 / 12
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
12
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
